Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study

BACKGROUND: Recent studies of fibroblast growth factor 21 (FGF21), first recognized as a regulator of glucose and lipid metabolism, have found that the level of in serum FGF21 is associated with the prognosis of many cardiovascular diseases, but its relationship to acute heart failure (AHF) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Guihai, Wu, Shenglin, Yan, Jingyi, Gao, Shanshan, Zhu, Jinxiu, Yue, Minghui, Li, Zexin, Tan, Xuerui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965840/
https://www.ncbi.nlm.nih.gov/pubmed/35369322
http://dx.doi.org/10.3389/fcvm.2022.834967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965840/
https://www.ncbi.nlm.nih.gov/pubmed/35369322
http://dx.doi.org/10.3389/fcvm.2022.834967

Ejemplares similares